SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending as its stock experiences a notable post-earnings sell-off despite a blowout report and strong guidance, leading to community discussions centered on alleged market manipulation and "premium harvesting" against the backdrop of ongoing debates about AI sector valuation.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is surging following better-than-expected financial results, reporting a surprise Q4 profit and raising revenue guidance, signaling a significant operational turnaround. The community is buzzing about new oncology and expanded infectious disease agreements leveraging its Matrix-M adjuvant technology, which combined with high short interest, is fueling strong short squeeze sentiment and excitement for future partnerships.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is surging following its strong Q4 revenue beat, raised 2026 guidance, and major contract awards like the $151 billion SHIELD defense program, fueling intense community debate between bullish investors anticipating a short squeeze and skeptics highlighting ongoing losses and high valuation.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy is trending after a substantial earnings miss and weak guidance led to a significant stock drop, causing widespread community distrust in management, though some investors see it as an oversold opportunity in the growing energy storage sector.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is actively discussed after a recent earnings report signaled stabilization in its BetterHelp segment and offered clarity on debt, leading to community speculation about the stock's extreme undervaluation and potential for a short squeeze, particularly with extended legislative support for telehealth.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. is experiencing extreme volatility as federal approval to restart its Santa Ynez pipeline clashes with ongoing lawsuits from California environmental groups and the state. The community fiercely debates whether federal preemption will lead to a significant short squeeze or if persistent regulatory hurdles, a recent stock offering, and an ongoing SEC investigation will ultimately hinder operations.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is surging as the community keenly watches its response to Paramount Global's raised bid for Warner Bros. Discovery, with many shareholders actively advocating for Netflix to abandon the deal and secure a significant breakup fee, expecting this outcome to be highly bullish amid ongoing regulatory and political headwinds.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

UniQure is trending after the FDA indicated that its AMT-130 gene therapy data for Huntington's disease is currently insufficient for a Biologics License Application, leading to intense community debate regarding the FDA's evolving stance on rare disease drug approvals and potential future pathways.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending after reporting strong recent earnings that showcased robust growth and distribution expansion through Pepsi, yet the stock has experienced significant volatility, sparking community debate over CEO John Fieldly's leadership and the impact of broader market conditions.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending after reporting a significant earnings beat and robust revenue growth, but the community is expressing widespread frustration over the stock's stagnant price and a perceived lack of transparency from management regarding pipeline updates, fueling ongoing buyout speculation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Citigroup Inc. Sells 2,390 Shares of Medpace Holdings, Inc. $MEDP

Citigroup Inc. reduced its holdings in Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 2.4% during the third quarter, according to its most recent 13F filing with the Securities & Exchange...

Vulcan Value Partners LLC Has $103.24 Million Stake in Medpace Holdings, Inc. $MEDP

Vulcan Value Partners LLC lowered its holdings in Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 30.4% in the third quarter, according to the company in its most recent Form 13F filing with...

Vanguard Group Inc. Sells 107,651 Shares of Medpace Holdings, Inc. $MEDP

Vanguard Group Inc. trimmed its holdings in shares of Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 4.5% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund...

Skandinaviska Enskilda Banken AB publ Has $3.86 Million Position in Medpace Holdings, Inc. $MEDP

Skandinaviska Enskilda Banken AB publ lowered its holdings in Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 87.3% in the third quarter, according to its most recent Form 13F filing with the...

Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge and Pipeline Fragility

Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge and Pipeline Fragility Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge...

Rep. Gilbert Ray Cisneros, Jr. Sells Medpace Holdings, Inc. (NASDAQ:MEDP) Shares

Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of Medpace Holdings, Inc. (NASDAQ:MEDP). In a filing disclosed on February 13th, the Representative disclosed that they...

Pallas Capital Advisors LLC Increases Position in Medpace Holdings, Inc. $MEDP

Pallas Capital Advisors LLC lifted its position in shares of Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 154.1% during the third quarter, according to the company in its most recent filing...

Medpace Holdings, Inc. (NASDAQ:MEDP) Given Consensus Rating of "Hold" by Analysts

Shares of Medpace Holdings, Inc. (NASDAQ:MEDP - Get Free Report) have earned a consensus recommendation of "Hold" from the fourteen brokerages that are covering the company, Marketbeat Ratings...

Medpace Holdings, Inc. $MEDP Shares Sold by Rhumbline Advisers

Rhumbline Advisers trimmed its stake in shares of Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 5.8% during the third quarter, according to its most recent filing with the Securities and...

Cibc World Market Inc. Makes New $5.03 Million Investment in Medpace Holdings, Inc. $MEDP

Cibc World Market Inc. acquired a new position in shares of Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the...

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: United States, Europe, Belgium, Asia-Pacific, and Other. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

MEDP
Medpace Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MEDP News

MEDPMedpace Holdings Inc